What would you say are the biggest advantages of having a centralized center of excellence? And how does that structure help reduce that technical risk and accelerate development compared with these more decentralized models?

So I don't think of this really as a centralization.

I think of it as an integration.

So when we think about gene therapy, it is a complex modality, as we all know.

And it has a set of problems that I think are all interconnected and tied together.

You need to understand the disease biology, and then you need to write payload.

You need to deliver it exactly to the right cells.

Where do you see AI creating the greatest value in genomic medicine? Do you see it creating value? And where do you think expectations are kind of outpacing what's really going on?